Sarah Jeanne Schrauben, MD, MSCE
Assistant Professor of Medicine (Renal-Electrolyte and Hypertension) at the Hospital of the University of Pennsylvania
Nephrologist, University of Pennsylvania Health System
Senior Fellow, Leonard Davis Institute of Health Economics, University of Pennsylvania
Senior Scholar, Clinical Center for Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania
Faculty Affiliate, Center for Health Incentives and Behavioral Economics, University of Pennsylvania
Research Associate, Population Aging Research Center, University of Pennsylvania
Department: Medicine
Contact information
Department of Medicine
Division of Renal, Electrolyte, and Hypertension
3400 Spruce Street
1 Founders, Renal Suite
Philadelphia, PA 19103
Division of Renal, Electrolyte, and Hypertension
3400 Spruce Street
1 Founders, Renal Suite
Philadelphia, PA 19103
Education:
BS (Human Biology)
Michigan State University, 2007.
MD (Medicine)
Michigan State University College of Human Medicine, 2011.
MSCE (Clinical Epidemiology)
University of Pennsylvania, 2017.
Permanent linkBS (Human Biology)
Michigan State University, 2007.
MD (Medicine)
Michigan State University College of Human Medicine, 2011.
MSCE (Clinical Epidemiology)
University of Pennsylvania, 2017.
Description of Clinical Expertise
Chronic Kidney Disease, Hypertension, Shared-decision makingDescription of Research Expertise
Sarah Schrauben, MD, MSCE is Assistant Professor of Medicine and Epidemiology in the Division of Renal, Electrolyte, and Hypertension, and Department of Biostatistics, Epidemiology, and Informatics at the Perelman School of Medicine and a Senior Scholar in the Center for Clinical Epidemiology and Biostatistics at the University of Pennsylvania. Her research focuses on the impact of health behaviors and modifiable risk factors in the development and management of chronic kidney disease (CKD) and its complications, as well as addressing implementation gaps of evidence-based care in CKD. She has contributed to the growing evidence base that seeks to prioritize behavior recommendations for management of CKD as well as assessing barriers to healthy behavior engagement. She has conducted studies that have identified high levels of substandard health behavior engagement among adults with CKD and phenotypes of behavior engagement that associate with clinical outcomes in this population. Her work also has assessed for real-time barriers to health behaviors by interviewing patients with CKD and developing a patient-centered behavioral intervention that leverages mobile health technology to increase engagement in healthy behaviors. She is currently conducting feasibility testing of the intervention in a clinical trial. Dr. Schrauben’s research aims to address implementation gaps in evidence-based CKD care. She is currently expanding her investigations in disease management by exploring the impact of functional status among those with CKD and multi-morbidity. Her future work aims to guide the development of innovative strategies to improve clinical and patient-reported outcomes in CKD.Selected Publications
White DM, Kimmel PL, Dember LM, Wilkie C, Edwards DP, Williams J, Bernardo L, Quintana N, Cheatle MD, Lash JP, Fischer M, Schmidt R, Doorenbos A, Schrauben SJ, Johansen KL. : Correction to: Fall Risk in Maintenance Hemodialysis Patients: A Secondary Analysis of the HOPE Consortium Trial. Clinical Journal of the American Society of Nephrology 20(11): 1645, November 2025 Notes: Epub 2025 Sep 24.Schrauben SJ, Nair D, Brown RT, Zhang X, Shlipak M, Tangri N, Yang W: Longitudinal Measures of Short Physical Performance Battery and Risk for CKD Progression and Death. J Am Soc Nephrol 36(10S), Oct 2025.
David M White, Paul L Kimmel, Laura M Dember, Caroline Wilkie, Dawn P Edwards, Joel Williams, Leah Bernardo, Nina Quintana, Martin D Cheatle, James P Lash, Michael J Fischer, Rebecca Schmidt, Ardith Doorenbos, Sarah Schrauben, Kirsten L Johansen; HOPE Consortium, a member of the HEAL Initiative: Patient Engagement in the Design and Conduct of the HOPE Trial: Addressing Chronic Pain in Hemodialysis Patients Clin J Am Soc Nephrol 20(10): 1461-1469, October 2025 Notes: Epub 2025 Aug 18.
Schrauben SJ, Brown RT, Zhang X, Shlipak M, Tangri N, Lash J, Leonard M, Appel L, Yang W: Longitudinal Changes in Physical Performance and Strength in People with CKD. J Am Soc Nephrol 36(10S), Oct 2025.
Bharwani S, Xu Y, Greenberg JH, Abraham AG, Schelling JR, Coca SG, Schrauben SJ, Waikar SS, Gutierrez OM, Shlipak M, Ix JH, Warady BA, Kimmel PL, Bonventre JV, Parikh CR, Denburg M, Furth SL, Ramachandran VS, Krasnow E: Association of Urine Uromodulin CKD Progression in Children. J Am Soc Nephrol 36(10S), Oct 2025.
Charytan DM, Moss AH, Shalak M, Wu W, Dember LM, Hsu JY, Kuzla N, Esserman D, Kalim S, Kimmel PL, Lockwood MB, Miyawaki N, Pellegrino B, Pun P, Qamhiyeh R, Scherer J, Schrauben SJ, Weiner DE, Mehrotra R. : Fall Risk in Maintenance Hemodialysis Patients: A Secondary Analysis of the HOPE Consortium Trial. Clinical Journal of the American Society of Nephrology 20(9): 1247-1258, July 2025.
Greenberg JH, Abraham AG, Xu Y, Schelling JR, Coca SG, Schrauben SJ, Wilson FP, Waikar SS, Vasan RS, Gutierrez OM, Shlipak MG, Ix JH, Warady BA, Kimmel PL, Bonventre JV, Parikh CR, Denburg M, Furth S; CKD Biomarkers Consortium.: Biomarker Panels for Discriminating Risk of CKD Progression in Children. J Am Soc Nephrol 36(6): 1105-1115, June 2025 Notes: Epub 2025 Jan 16.
Schrauben SJ, Greenberg J, Coca S, Waikar S, Gutierrez O, Schelling J, Ix J, Shilpak M, Parikh P, Kimmel P, Sarnak M, Ramachandran V, Feldman HI, Bonventre J. : Urine Biomarkers for Diabetic Kidney Disease Progression in Participants of the Chronic Renal Insufficiency Cohort Study. Clinical Journal of the American Society of Nephrology 20(7): 958-967, June 2025.
Lopez-Silva C, Surapaneni A, Coresh J, Chen TK, Schlosser P, Rhee EP, Waikar SS, Schmidt IM, Deo R, Ganz P, Dubin R, Ramachandran VS, Kimmel PL, Schrauben SJ Parikh CR, Bonventre JV, Dobre M, Rao PS, Ricardo AC, Weir M, Grams ME. : Circulating Proteins for Prediction of Kidney Disease Progression and Cardiovascular Outcomes: Individual Participant Data Meta-Analysis of Four Cohorts. Am J Nephrol 30: 1-12, June 2025 Notes: Online ahead of print.
Tamargo CL, Coca SG, Thiessen Philbrook H, Hu DG, Ix JH, Shlipak MG, Fried LF, Gutierrez OM, Waikar SS, Schrauben SJ, Schelling JR, Ganz P, Kimmel PL, Greenberg JH, Deo R, Takakura A, Ramachandran VS, Bonventre JV, Parikh CR. : The distal nephron biomarkers associate with diabetic kidney disease progression. JCI Insight 10(12): e186836, June 2025.